SORATINEX Notification CPNP

Notification – CPNP (Cosmetic Products Notification Portal) Cosmetics legislation at EU level requires that all products to be marketed in the EU must be registered in the Cosmetic Products Notification Portal (CPNP) before being placed on the market: http://ec.europa.eu/growth/sectors/cosmetics/index_en.htm

REFERENCES – CLINICAL STUDIES

Double-blinded clinical studies made in Austria	Semmelweis University study
Download	Download

IMPORTANT NOTE FROM THE EU IMPORTER

Dear Patients, we would like to let you know that in the process of rebranding we decided to change our former brand name (DR MICHAELS) to a new more suitable name SORATINEX for the new market launches of this revolutionary product. Therefore whenever you come across a reference to DR MICHAELS, then please always remember: SORATINEX is DR MICHAELS – it is just the name that has changed, nothing else. The two products are exactly the same in terms of ingredients and manufacturing. Both are made by Dr. Michael Tirant PhD, Australia. We hope this will not cause any confusion, and that you will appreciate and like our new brand name and design.